Oncoimmunology

No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19.

Petrazzuolo A, Le Naour J, Vacchelli E, ..., Smadja DM, Kroemer G

Oncoimmunology 9 (1) 1857112 [2020-12-08; online 2020-12-08]

Category: Genomics & transcriptomics Category: Health Type: Journal article

Immune responses during COVID-19 infection.

Melenotte C, Silvin A, Goubet AG, ..., Derosa L, Zitvogel L

Oncoimmunology 9 (1) 1807836 [2020-08-25; online 2020-08-25]

Type: Review

Repurposing CD8 + T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

Gujar S, Pol JG, Kim Y, Kroemer G

Oncoimmunology 9 (1) 1794424 [2020-07-16; online 2020-07-16]

Type: Review

Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses.

Liu P, Zhao L, Ferrere G, ..., Kepp O, Kroemer G

Oncoimmunology 9 (1) 1789284 [2020-07-08; online 2020-07-08]

Category: Biochemistry Type: Journal article

COVID-19: a challenge for oncology services.

Routy B, Derosa L, Zitvogel L, Kroemer G

Oncoimmunology 9 (1) 1760686 [2020-05-05; online 2020-05-05]

Type: Other